128 related articles for article (PubMed ID: 26235905)
1. Anti-inflammatory and anti-bacterial effects of iron chelation in experimental sepsis.
Islam S; Jarosch S; Zhou J; Parquet Mdel C; Toguri JT; Colp P; Holbein BE; Lehmann C
J Surg Res; 2016 Jan; 200(1):266-73. PubMed ID: 26235905
[TBL] [Abstract][Full Text] [Related]
2. The novel iron chelator, DIBI, attenuates inflammation and improves outcome in colon ascendens stent peritonitis-induced experimental sepsis.
Fokam D; Aali M; Dickson K; Scott C; Holbein B; Zhou J; Lehmann C
Clin Hemorheol Microcirc; 2020; 76(2):241-261. PubMed ID: 32925011
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of a novel iron chelator, DIBI, in experimental sepsis.
Thorburn T; Aali M; Kostek L; LeTourneau-Paci C; Colp P; Zhou J; Holbein B; Hoskin D; Lehmann C
Clin Hemorheol Microcirc; 2017; 67(3-4):241-250. PubMed ID: 28869457
[TBL] [Abstract][Full Text] [Related]
4. Acute administration of antibiotics modulates intestinal capillary perfusion and leukocyte adherence during experimental sepsis.
Al-Banna NA; Pavlovic D; Bac VH; Utpatel K; Janke E; Rippke JN; Borowiak M; Cerny V; Spassov A; Johnston B; Issekutz TB; Lehmann CH
Int J Antimicrob Agents; 2013 Jun; 41(6):536-43. PubMed ID: 23622880
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory iron chelator, DIBI, reduces leukocyte-endothelial adhesion and clinical symptoms of LPS-induced interstitial cystitis in mice.
Hagn G; Holbein B; Zhou J; Lehmann C
Clin Hemorheol Microcirc; 2021; 79(3):395-406. PubMed ID: 34250933
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effects of gender and estradiol treatment on the intestinal microcirculation during experimental sepsis.
Sharawy N; Pavlovic D; Wendt M; Cerny V; Lehmann C
Microvasc Res; 2011 Nov; 82(3):397-403. PubMed ID: 21756921
[TBL] [Abstract][Full Text] [Related]
7. Combination of dehydroepiandrosterone and orthovanadate administration reduces intestinal leukocyte recruitment in models of experimental sepsis.
Al-Banna N; Pavlovic D; Sharawi N; Bac VH; Jaskulski M; Balzer C; Weber S; Nedeljkov V; Lehmann C
Microvasc Res; 2014 Sep; 95():82-7. PubMed ID: 25086183
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.
Dinc G; Demiraslan H; Elmali F; Ahmed SS; Metan G; Alp E; Doganay M
Chemotherapy; 2013; 59(5):325-9. PubMed ID: 24525528
[TBL] [Abstract][Full Text] [Related]
9. Argatroban administration reduces leukocyte adhesion and improves capillary perfusion within the intestinal microcirculation in experimental sepsis.
Fuchs C; Ladwig E; Zhou J; Pavlovic D; Behrend K; Whynot S; Hung O; Murphy M; Cerny V; Lehmann C
Thromb Haemost; 2010 Nov; 104(5):1022-8. PubMed ID: 20806115
[TBL] [Abstract][Full Text] [Related]
10. Anti-Inflammatory Effects of the Iron Chelator, DIBI, in Experimental Acute Lung Injury.
Lehmann C; Alizadeh-Tabrizi N; Hall S; Faridi S; Euodia I; Holbein B; Zhou J; Chappe V
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807282
[TBL] [Abstract][Full Text] [Related]
11. DIBI, a polymeric hydroxypyridinone iron chelator, reduces ocular inflammation in local and systemic endotoxin-induced uveitis.
Arora N; Caldwell A; Wafa K; Szczesniak A; Caldwell M; Al-Banna N; Sharawy N; Islam S; Zhou J; Holbein BE; Kelly MEM; Lehmann C
Clin Hemorheol Microcirc; 2018; 69(1-2):153-164. PubMed ID: 29630535
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin along with imipenem attenuates acute lung injury in sepsis through decrease in inflammatory mediators and bacterial load.
Choudhury S; Kandasamy K; Maruti BS; Addison MP; Kasa JK; Darzi SA; Singh TU; Parida S; Dash JR; Singh V; Mishra SK
Eur J Pharmacol; 2015 Oct; 765():447-56. PubMed ID: 26375251
[TBL] [Abstract][Full Text] [Related]
13. Imipenem alters systemic and liver inflammatory responses in CLP- induced sepsis mice in a dose-dependent manner.
Khosrojerdi A; Soudi S; Zavaran Hosseini A; Ghaffari Khaligh S; Hashemi SM
Int Immunopharmacol; 2021 Apr; 93():107421. PubMed ID: 33548581
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.
Vianna RC; Gomes RN; Bozza FA; Amâncio RT; Bozza PT; David CM; Castro-Faria-Neto HC
Shock; 2004 Feb; 21(2):115-20. PubMed ID: 14752283
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of iron withdrawal by chelation on the growth of human and murine mammary carcinoma and fibrosarcoma cells.
Power Coombs MR; Grant T; Greenshields AL; Arsenault DJ; Holbein BE; Hoskin DW
Exp Mol Pathol; 2015 Oct; 99(2):262-70. PubMed ID: 26210486
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Treatment Effects of Different Iron Chelators in Experimental Models of Sepsis.
Lehmann C; Aali M; Zhou J; Holbein B
Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33466819
[TBL] [Abstract][Full Text] [Related]
17. Efficiency of Emulsified Particle-Associated Polyhexamethylenbiguanid-Hydrochlorid (Polihexanide) for Peritoneal Lavage in a Murine Sepsis Model.
Diedrich S; Müller G; Sandbrink C; Papke R; van der Linde J; Heidecke CD; Parteke LI; Assadian O; Kramer A
Surg Infect (Larchmt); 2018 Oct; 19(7):723-728. PubMed ID: 30260766
[TBL] [Abstract][Full Text] [Related]
18. DIBI, a novel 3-hydroxypyridin-4-one chelator iron-binding polymer, inhibits breast cancer cell growth and functions as a chemosensitizer by promoting S-phase DNA damage.
Greenshields AL; Power Coombs MR; Fernando W; Holbein BE; Hoskin DW
Biometals; 2019 Dec; 32(6):909-921. PubMed ID: 31624972
[TBL] [Abstract][Full Text] [Related]
19. Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis.
Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Orlando F; Mocchegiani F; Silvestri C; Licci A; Łukasiak J; Saba V; Scalise G
J Infect Dis; 2005 Nov; 192(9):1613-20. PubMed ID: 16206076
[TBL] [Abstract][Full Text] [Related]
20. The influence of G-CSF addition to antibiotic treatment of experimental sepsis on pulmonary tissue.
Aydin S; Caylan R; Aydin K; Yulug E; Yenilmez E; Koksal I
J Natl Med Assoc; 2005 Nov; 97(11):1489-95. PubMed ID: 16334496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
